4/A
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001209191-22-033984
Chief Financial Officer acquired 1,270,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Greenway Schond L. Chief Financial Officer | 2022-05-23 | Grant or award | +1,270,000 | 1,270,000 | D | ||
| Derivatives | |||||||
| Greenway Schond L. Chief Financial Officer | 2022-05-23 | Grant or award · Stock Option (Right to Buy) | +1,650,000 | 1,650,000 | D | ||
Loading xslF345X03/doc4a.xml…